Stock comparison
Intellia Therapeutics, Inc. is 1.0x more valuable than NEOGEN CORP by market capitalization ($2.16 B vs $2.12 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NTLA is larger
Intellia Therapeutics, Inc. is 1.0x more valuable than NEOGEN CORP by market capitalization ($2.16 B vs $2.12 B).
Market value leader
NTLA
Intellia Therapeutics, Inc. is 1.0x more valuable than NEOGEN CORP by market capitalization ($2.16 B vs $2.12 B).
Revenue leader
NEOG
NEOG: $894.66M vs NTLA: $67.67M.
Profit leader
NTLA
NEOG: -$1.09B vs NTLA: -$412.69M.
Margin leader
NEOG
NEOG: -122.1% vs NTLA: -609.9% net margin.
| Metric | NEOG | NTLA |
|---|---|---|
| Market cap | $2.12 B | $2.16 B |
| US-listed rank | #2092 | #2076 |
| Revenue (latest FY) | $894.66M | $67.67M |
| Net income (latest FY) | -$1.09B | -$412.69M |
| Net margin | -122.1% | -609.9% |
| P/E (trailing FY) | - | - |
| SEC filings | 1,894 | 679 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Intellia Therapeutics, Inc. is 1.0x more valuable than NEOGEN CORP by market capitalization ($2.16 B vs $2.12 B).
In their latest fiscal years, NEOGEN CORP reported $894.66M in revenue while Intellia Therapeutics, Inc. reported $67.67M.
Full pages: NEOGEN CORP and Intellia Therapeutics, Inc., or browse the full rankings.